
Reproductive rights advocates are on edge over a lawsuit to revoke the decades-old Food and Drug Administration (FDA) approval of mifepristone, which, if successful, would end legal access to abortion pills nationwide.
Advocates and legal experts say the suit has no merit, but they fear conservative courts will think otherwise.
Abortion pills have become one of the next major fronts in the fight over reproductive health care in the wake of the Supreme Court’s decision overturning Roe v. Wade, and the lawsuit is seen by both sides as the start of the battle to come.
Mifepristone, a drug that blocks hormones necessary for pregnancy, was approved by the FDA in 2000. It is used with a second drug called misoprostol, which causes contractions and essentially induces a miscarriage.